HI

Health Italia SpAMIL Health Stock Report

Last reporting period 30 Jun, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

0.055

Micro

Exchange

XMIL - Borsa Italiana S.P.A.

HI.MI Stock Analysis

HI

Neutral

Based on Eyestock quantitative analysis, HI.MI`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

52/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

249.1 %

Undervalued

Market cap $B

0.055

Dividend yield

0.53 %

Shares outstanding

18.971 B

Health Italia SpA engages in the promotion of integrated and alternative healthcare solutions. The company is headquartered in Formello, Roma and currently employs 117 full-time employees. The company went IPO on 2017-02-09. The firm provides medical services, through its subsidiaries and affiliates. Health Italia SpA operates through several entities, including Basis Cliniche Srl, which is specialized in the management of polyclinics and dental centers laboratories; Coopsalute SCpA, which provides welfare and health care services through a network of health professionals and affiliated structures; Scegliere Salute Srl, which deals with the research about healthcare clinics; Impresa Sanitaria Alfa 88 Srl, which runs clinics and nursing homes in the municipality of Rome, and Janua Broker SpA, which is specialized in the business of health care.

View Section: Eyestock Rating